Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0KS1Z
|
||||
Former ID |
DIB019391
|
||||
Drug Name |
compound 26c
|
||||
Drug Type |
Small molecular drug
|
||||
Structure |
Download2D MOL |
||||
Formula |
C40H55Cl2N5O3
|
||||
InChI |
InChI=1S/C40H53N5O3.2ClH/c1-6-7-21-45-38-32(19-12-20-42-38)35(29-17-11-18-31(23-29)48-22-13-16-28-14-9-8-10-15-28)37(39(45)46)44-40(47)43-36-33(26(2)3)24-30(41)25-34(36)27(4)5;;/h11-12,17-20,23-28H,6-10,13-16,21-22,41H2,1-5H3,(H2,43,44,47);2*1H
|
||||
InChIKey |
ZFNNBIMQDHBELV-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Acetyl-CoA acetyltransferase, mitochondrial | Target Info | Inhibitor | [527814] | |
KEGG Pathway | Fatty acid degradation | ||||
Synthesis and degradation of ketone bodies | |||||
Valine, leucine and isoleucine degradation | |||||
Lysine degradation | |||||
Tryptophan metabolism | |||||
Pyruvate metabolism | |||||
Glyoxylate and dicarboxylate metabolism | |||||
Propanoate metabolism | |||||
Butanoate metabolism | |||||
Terpenoid backbone biosynthesis | |||||
Metabolic pathways | |||||
Biosynthesis of antibiotics | |||||
Carbon metabolism | |||||
Fatty acid metabolism | |||||
NetPath Pathway | Leptin Signaling Pathway | ||||
PANTHER Pathway | CCKR signaling map ST | ||||
References | |||||
Ref 527814 | Bioorg Med Chem Lett. 2006 Jan 1;16(1):44-8. Epub 2005 Oct 18.Synthesis and biological activity of novel 4-phenyl-1,8-naphthyridin-2(1H)-on-3-yl ureas: potent acyl-CoA:cholesterol acyltransferase inhibitor with improved aqueous solubility. | ||||
Ref 541834 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6734). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.